Drug(薬物リスト) DrugBank | All Description Patterns💬 Info on mouse-over

19 / 17,542 descriptions

No. 薬物名(臨床試験情報から抽出) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY
On map, Yellow: Drug target genes
指定難病告示番号
1 Act-385781a (actelion epoprostenol) Epoprostenol 2件: D00106, D01337 💬 1件: PTGIR 💬 3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 1件: 86 💬
2 Combination injection of epo and g-csf Filgrastim 1件: D03235 💬 1件: CSF3R 💬 5件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 1件:  6  💬
3 Current marketed flolan (epoprostenol sodium) Epoprostenol 2件: D00106, D01337 💬 1件: PTGIR 💬 3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 1件: 86 💬
4 Epo - - - - 1件: 13 💬
5 Epoeitin beta - - - - 1件: 18 💬
6 Epoetin alfa Erythropoietin 1件: D03231 💬 1件: EPOR 💬 5件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 3件: 13, 18, 46 💬
7 Epoetin beta Erythropoietin 1件: D03231 💬 1件: EPOR 💬 5件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 1件: 13 💬
8 Epoprostenol Epoprostenol 2件: D00106, D01337 💬 1件: PTGIR 💬 3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 1件: 86 💬
9 Epoprostenol for injection Epoprostenol 2件: D00106, D01337 💬 1件: PTGIR 💬 3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 1件: 86 💬
10 Epoprostenol sodico Epoprostenol 2件: D00106, D01337 💬 1件: PTGIR 💬 3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 1件: 86 💬
11 Epoprostenol sodium Epoprostenol 2件: D00106, D01337 💬 1件: PTGIR 💬 3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 1件: 86 💬
12 Epoprostenol-actelion Epoprostenol 2件: D00106, D01337 💬 1件: PTGIR 💬 3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 1件: 86 💬
13 Epoprostenolo per iniezione - - - - 1件: 86 💬
14 Erythropoetin (epo) - - - - 1件:  2  💬
15 Erythropoietin Erythropoietin 1件: D03231 💬 1件: EPOR 💬 5件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 9件:  2 ,  6 , 13, 18, 22, 47, 70, 95, 96 💬
16 Erythropoietin human recombinant (eporh) Erythropoietin 1件: D03231 💬 1件: EPOR 💬 5件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 1件:  6  💬
17 New thermo stable formulation of epoprostenol sodium Epoprostenol 2件: D00106, D01337 💬 1件: PTGIR 💬 3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 1件: 86 💬
18 Recombinant human erythropoietin Erythropoietin 1件: D03231 💬 1件: EPOR 💬 5件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 1件: 13 💬
19 Recombinant human erythropoietin(rhepo) Erythropoietin 1件: D03231 💬 1件: EPOR 💬 5件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 1件:  2  💬